These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 28535469

  • 1. Novel propanamides as fatty acid amide hydrolase inhibitors.
    Deplano A, Morgillo CM, Demurtas M, Björklund E, Cipriano M, Svensson M, Hashemian S, Smaldone G, Pedone E, Luque FJ, Cabiddu MG, Novellino E, Fowler CJ, Catalanotti B, Onnis V.
    Eur J Med Chem; 2017 Aug 18; 136():523-542. PubMed ID: 28535469
    [Abstract] [Full Text] [Related]

  • 2. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
    Deplano A, Karlsson J, Svensson M, Moraca F, Catalanotti B, Fowler CJ, Onnis V.
    J Enzyme Inhib Med Chem; 2020 Dec 18; 35(1):815-823. PubMed ID: 32200655
    [Abstract] [Full Text] [Related]

  • 3. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
    Deplano A, Cipriano M, Moraca F, Novellino E, Catalanotti B, Fowler CJ, Onnis V.
    J Enzyme Inhib Med Chem; 2019 Dec 18; 34(1):562-576. PubMed ID: 30688118
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.
    Sunduru N, Svensson M, Cipriano M, Marwaha S, Andersson CD, Svensson R, Fowler CJ, Elofsson M.
    J Enzyme Inhib Med Chem; 2017 Dec 18; 32(1):513-521. PubMed ID: 28114819
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.
    Tarzia G, Duranti A, Tontini A, Piersanti G, Mor M, Rivara S, Plazzi PV, Park C, Kathuria S, Piomelli D.
    J Med Chem; 2003 Jun 05; 46(12):2352-60. PubMed ID: 12773040
    [Abstract] [Full Text] [Related]

  • 16. O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.
    Colombano G, Albani C, Ottonello G, Ribeiro A, Scarpelli R, Tarozzo G, Daglian J, Jung KM, Piomelli D, Bandiera T.
    ChemMedChem; 2015 Feb 05; 10(2):380-95. PubMed ID: 25338703
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
    Fowler CJ, Björklund E, Lichtman AH, Naidu PS, Congiu C, Onnis V.
    J Enzyme Inhib Med Chem; 2013 Feb 05; 28(1):172-82. PubMed ID: 22225576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
    Glaser ST, Gatley SJ, Gifford AN.
    J Pharmacol Exp Ther; 2006 Mar 05; 316(3):1088-97. PubMed ID: 16278311
    [Abstract] [Full Text] [Related]

  • 20. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure.
    Lodola A, Rivara S, Mor M.
    Adv Protein Chem Struct Biol; 2011 Mar 05; 85():1-26. PubMed ID: 21920320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.